Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/06/2005US20050222037 Modulates cell adhesion, angiogenesis, maintenance of vascular integrity, regulation of vascular permeability
10/06/2005US20050222036 Peptide compositions with effects on blood glucose
10/06/2005US20050222035 Peptides and related molecules that modulate nerve growth factor activity
10/06/2005US20050222034 blocking cell cycle progression in abnormally proliferating cells
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050222032 Polynucleotide and polypeptide molecules for zacrp2, a novel member of the family of proteins bearing a collagen-like domain and a C1q domain
10/06/2005US20050222031 Method for preventing or treating malignant melanoma
10/06/2005US20050222030 Modified annexin proteins and methods for preventing thrombosis
10/06/2005US20050222029 Compositions and methods for treating diseases
10/06/2005US20050222028 BMP-9 compositions and methods for inducing differentiation of cholinergic neurons
10/06/2005US20050222027 Modulation of complement to treat pain
10/06/2005US20050222026 Purified nitrosylated albumin variant of an amino acid sequence of human serum albumin; antimicrobial
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222024 Stabilized albumin preparations
10/06/2005US20050222022 administering to a mammal stem cell factor in an amount sufficient to induce neuroproliferation from endogenous cells, can induce migration of stem cells to neural tissue and/or induce proliferation and/or differentiation of such cells into neurons
10/06/2005US20050222021 Immunomodulators; for treatment of inflammation
10/06/2005US20050222020 Apoptotically active peptides
10/06/2005US20050222019 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
10/06/2005US20050222017 Apoptosis promoter and inhibitor interacting with cgi-94, and method of screening the same
10/06/2005US20050222016 Nucleoside analogs in combination therapy of herpes simplex infections
10/06/2005US20050222015 Dehydrodidemnin B
10/06/2005US20050222014 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture
10/06/2005US20050222013 Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
10/06/2005US20050222012 Methods and compositions for treating leukemia
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050222010 Composition for treating or preventing hyperuricemia
10/06/2005US20050222009 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier
10/06/2005US20050222007 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
10/06/2005US20050222006 Aggregates of human insulin derivatives
10/06/2005US20050221489 Recombinant negative strand virus rna expression systems and vaccines
10/06/2005US20050221487 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
10/06/2005US20050221460 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
10/06/2005US20050221458 proteins having oxidase or oxidoreductase activity, used to control growth of insects, enabling finer silk thread production; gene expression inhibition; genetic engineering
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221441 Protein has N terminal hairpin domain and subsequent four kringle domains; hepatocyte growth factor antagonists; angiogenesis inhibitors; deletion or substitution mutants; antitumor and antimetastatic biodrugs
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221439 Genes of an otitis media isolate of haemophilus influenzae
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221437 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/06/2005US20050221436 Human neuropeptide Y-like G protein-coupled receptor
10/06/2005US20050221435 Biological material for preparing pharmaceutical compositions intended for treating mammals
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221433 IL-18 specific polypeptides and therapeutic uses thereof
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221430 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
10/06/2005US20050221422 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221395 Methods and products based on oligomerization of stress proteins
10/06/2005US20050221388 Molecular interactions in hematopoietic cells
10/06/2005US20050221381 Method for isolating ligands
10/06/2005US20050221376 Metalloproteinase ADAM 22
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221359 Cospeptin, cosmedin and their uses
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221331 Osteoprotegerin
10/06/2005US20050221305 Antigen panels and methods of using the same
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221299 Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
10/06/2005US20050221298 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
10/06/2005US20050221292 Vectors with modified protease-dependent tropism
10/06/2005US20050221291 Dc-sign isoforms, related compositions and methods for their use in disease therapy
10/06/2005US20050221288 Variant tat proteins and methods for use thereof
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050221285 Method for identifying or screening anti-viral agents
10/06/2005US20050220901 Methods of pharmaceutical separation from plants
10/06/2005US20050220886 Immobilized immunomodulators; antiinflammatory, anticarcinogenic agents, antiallergens; autoimmune diseases, asthma
10/06/2005US20050220876 Methods and composition of extended delivery of water insoluble drugs
10/06/2005US20050220846 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
10/06/2005US20050220821 Pressure sore treatment
10/06/2005US20050220820 Administering botulinum toxin to the patient, wherein excess levels of glandular secretion result in the conditions which are selected from seborrheic dermatitis, rhinophyma, seborrhea, seborrheic blepharitis and sebaceous cysts, whereby the excess levels of glandular secretions is reduced
10/06/2005US20050220812 Screening process
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220803 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
10/06/2005US20050220802 Vaccine and method for treatment of motor neurone diseases
10/06/2005US20050220801 Immunopotentiators
10/06/2005US20050220800 Cytokines and cytokine receptors with reduced immunogenicity
10/06/2005US20050220799 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
10/06/2005US20050220796 Compositions and methods for modulating DNA repair
10/06/2005US20050220792 Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization
10/06/2005US20050220791 Novel of cytokine inhibitors
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220782 Method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern
10/06/2005US20050220781 IFIX, a novel HIN-200 protein, for cancer therapy
10/06/2005US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties
10/06/2005US20050220779 Exert antiinflammatory effect by inhibiting inducible nitric oxide synthaseiand cyclooxygenase-2 expression, at level of transcription by suppressing activation of nuclear factor kappa B; cell-free assay
10/06/2005US20050220774 Methods of inducing differentiation in ex vivo expanded stem cells
10/06/2005US20050220773 Implant containing cells having growhfactor gene transferred thereinto
10/06/2005US20050220772 Stem cell screening and transplantation therapy for hiv infection
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220766 Viral vectors and methods for producing and using the same
10/06/2005US20050220764 Higher-doses of interferon-beta for treatment of multiple sclerosis
10/06/2005US20050220763 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
10/06/2005US20050220762 Modified human interferon polypeptides and their uses
1 ... 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 ... 3163